View Cart  

Mylan Can Market Generic Detrol LA in January 2014 Per Pfizer Settlement

A A
Mylan will be able to sell a generic version of Pfizer’s long-acting overactive bladder drug Detrol LA on Jan. 1, 2014, or earlier pending certain undisclosed terms of a settlement negotiated by the two drugmakers.

To View This Article:

Login

Subscribe To Drug Industry Daily